Blocking HARE or saturating it with HA can prevent direct binding of cancer cells to HARE+ cells through their HA-rich pericellular matrix and simultaneously the elevated blood levels of HA, created by lack of HARE-mediated clearance, might also saturate CD44 on the cancer cells, preventing them from utilizing this previously demonstrated important factor for extravasation. The gene discussed is CD44; the disease is cancer.